This peculiar distribution among BRAF functional classes in NSCLC is in contrast with data from melanoma and thyroid carcinoma patients, where TERT mutations have been mainly described in BRAF V600E-mutant tumors [71]. The gene discussed is TERT; the disease is melanoma.